科技: 人物 企业 技术 IT业 TMT
科普: 自然 科学 科幻 宇宙 科学家
通信: 历史 技术 手机 词典 3G馆
索引: 分类 推荐 专题 热点 排行榜
互联网: 广告 营销 政务 游戏 google
新媒体: 社交 博客 学者 人物 传播学
新思想: 网站 新书 新知 新词 思想家
图书馆: 文化 商业 管理 经济 期刊
网络文化: 社会 红人 黑客 治理 亚文化
创业百科: VC 词典 指南 案例 创业史
前沿科技: 清洁 绿色 纳米 生物 环保
知识产权: 盗版 共享 学人 法规 著作
用户名: 密码: 注册 忘记密码?
    创建新词条
科技百科
  • 人气指数: 6122 次
  • 编辑次数: 1 次 历史版本
  • 更新时间: 2009-04-16
admin
admin
发短消息
相关词条
盛之源
盛之源
美敦力公司
美敦力公司
健补养电子商务有限公司
健补养电子商务有限公司
中美史克制药有限公司
中美史克制药有限公司
云南白药集团
云南白药集团
英国葛兰素威康公司
英国葛兰素威康公司
英国联合博姿公司
英国联合博姿公司
英国阿斯利康公司
英国阿斯利康公司
英国单化联盟公司
英国单化联盟公司
英国葛兰素史克公司
英国葛兰素史克公司
推荐词条
希拉里二度竞选
希拉里二度竞选
《互联网百科系列》
《互联网百科系列》
《黑客百科》
《黑客百科》
《网络舆情百科》
《网络舆情百科》
《网络治理百科》
《网络治理百科》
《硅谷百科》
《硅谷百科》
2017年特斯拉
2017年特斯拉
MIT黑客全纪录
MIT黑客全纪录
桑达尔·皮查伊
桑达尔·皮查伊
阿里双十一成交额
阿里双十一成交额
最新词条

热门标签

微博侠 数字营销2011年度总结 政务微博元年 2011微博十大事件 美国十大创业孵化器 盘点美国导师型创业孵化器 盘点导师型创业孵化器 TechStars 智能电视大战前夜 竞争型国企 公益型国企 2011央视经济年度人物 Rhianna Pratchett 莱恩娜·普莱契 Zynga与Facebook关系 Zynga盈利危机 2010年手机社交游戏行业分析报告 游戏奖励 主流手机游戏公司运营表现 主流手机游戏公司运营对比数据 创建游戏原型 正反馈现象 易用性设计增强游戏体验 易用性设计 《The Sims Social》社交亮 心理生理学与游戏 Kixeye Storm8 Storm8公司 女性玩家营销策略 休闲游戏的创新性 游戏运营的数据分析 社交游戏分析学常见术语 游戏运营数据解析 iPad风行美国校园 iPad终结传统教科书 游戏平衡性 成长类型及情感元素 鸿蒙国际 云骗钱 2011年政务微博报告 《2011年政务微博报告》 方正产业图谱 方正改制考 通信企业属公益型国企 善用玩家作弊行为 手机游戏传播 每用户平均收入 ARPU值 ARPU 游戏授权三面观 游戏设计所运用的化学原理 iOS应用人性化界面设计原则 硬核游戏 硬核社交游戏 生物测量法研究玩家 全球移动用户 用户研究三部曲 Tagged转型故事 Tagged Instagram火爆的3大原因 全球第四大社交网络Badoo Badoo 2011年最迅猛的20大创业公司 病毒式传播功能支持的游戏设计 病毒式传播功能 美国社交游戏虚拟商品收益 Flipboard改变阅读 盘点10大最难iPhone游戏 移动应用设计7大主流趋势 成功的设计文件十个要点 游戏设计文件 应用内置付费功能 内置付费功能 IAP功能 IAP IAP模式 游戏易用性测试 生理心理游戏评估 游戏化游戏 全美社交游戏规模 美国社交游戏市场 全球平板电脑出货量 Facebook虚拟商品收益 Facebook全球广告营收 Facebook广告营收 失败游戏设计的数宗罪名 休闲游戏设计要点 玩游戏可提高认知能力 玩游戏与认知能力 全球游戏广告 独立开发者提高工作效率的100个要点 Facebook亚洲用户 免费游戏的10种创收模式 人类大脑可下载 2012年最值得期待的20位硅谷企业家 做空中概股的幕后黑手 做空中概股幕后黑手 苹果2013营收 Playfish社交游戏架构

史赛克公司 发表评论(0) 编辑词条

史赛克公司简介

  史赛克公司是全球最大的骨科及医疗科技公司之一

  史赛克公司是全球最大的骨科及医疗科技公司之一,总部设于美国密西根州的克拉马苏市,在全球有14个生产研发及销售分部,员工超过一万六千多人。产品涉及关节置换、创伤、颅面、脊柱、手术设备、神经外科、耳鼻喉、介入性疼痛管理、微创手术、导航手术、智能化手术室及网络通讯、生物科技、医用床、急救推床等。由于业绩良好,史赛克公司分别被美国著名的《财富》杂志及《Business Week》 评为财富500强公司及全美50大医疗公司之一。在2005年更被评为在医疗业界中最受景仰的公司。美国史赛克公司在纽约股票交易所上市

  美国史赛克公司亚太总部设于香港,支持史赛克公司在亚太地区多个国家的业务发展,包括大中华、澳洲、新西兰、韩国和东南亚地区;提供财务、人力资源市场推广信息管理产品策略支持。美国史赛克公司亚太地区总裁为Mr. Jim Cunniff。

Stryker Corporation NYSE: SYK, a global leader in orthopaedic manufacture, is a Kalamazoo, Michigan based medical technology firm engaged in the development and production of implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Presently, the company is divided into several discrete operational units, each functioning as a separate entity: Stryker Biotech; Stryker Canada; Stryker Communications; Stryker Craniomaxillofacial; Stryker Development; Stryker Endoscopy; Stryker Imaging; Stryker Japan; Stryker Latin America; Stryker MedSurg; Stryker Orthopaedics; and Stryker Spine.1

史赛克公司的名称由来

  二十世纪三十年代末,美国密西根大学整形外科一位名叫 Homer Stryker 的年轻好奇医生发现,某些医疗产品出现了短缺,不能满足他以及他的病人的需要。他没有接受当时医疗设备条件的限制,而是发挥他的创造性思维,发明了几种令整个医疗界都为之兴奋的新产品

  在密西根州的克拉马苏进行过实验后,史赛克医生继续针对整形外科问题设计出一些简单而又实用的解决方案,如史赛克翻转架,这是一张床,医疗专业人员可以用它来旋转不能移动的病人。到了 1941 年,市场对他的产品的需求非常大,因此史赛克医生创立了一家公司生产这些产品。他通过自己的实践,创造性发明了医疗史上使用最为广泛的产品之一:摆锯。摆锯使医生能够切开坚硬的物质,但又不会伤害里面的皮肤。

  有了希望开发出更好的医疗产品以提高人们生活质量这一强烈的渴望做动力,史赛克医生继续用他的远见和创新精神激励着这家公司。 1964 年,史赛克医生退休,为了表彰他矢志不渝地提高整形外科病人生活质量,这家公司更名为史赛克公司。

History

The Orthopedic Frame Company, precursor of Stryker Corporation, was formed on February 20, 1946 by Dr. Homer Stryker, a Kalamazoo, Michigan based orthopedist. Stryker, an innovator, desired to provide patients medical technologies that would both foster efficiency and observe demonstrated need. Accordingly, he developed the Turning Frame—a mobile hospital bed that allowed for repositioning of injured patients while providing necessary body immobility, the cast cutter—a cast cutting apparatus that removed cast material without damaging underlying tissues, and the walking heel, among others. In 1964, the company name underwent revision and was officially changed to Stryker Corporation.2

In 1978, one year after John Brown was named President and CEO, annual sales reached $22.7 million. In 1979 Stryker made an initial public offering of stock and later acquired Osteonics Corporation, entering the replacement hip, knee, and other orthopaedic implants market (Stryker). In 1999 annual sales reached $2.1 billion and in 2000 Stryker was included in the S&P 500 and the Forbes Platinum 400 for the first time. In 2002 sales reached $3.0 billion and Stryker was listed in the Fortune 500 for the first time.

In 2003 Stephen P. MacMillan joined Stryker as President and COO. In 2005, annual sales reached $4.9 billion and John W. Brown transitioned to the single role of Chairman of the Board while Steve MacMillan became President & CEO. By 2007, Stryker sold its Physiotherapy Associates division to private equity firm Water Street Healthcare Partners for $150 million.

As of 2007-2008 global market overview of top medical technology firms, Stryker maintains a number 10 locus with total portfolio sales in excess of $6 billion; this figure marks an increase of approximately 20% over the previous period. Since 1999 the company has sustained comparable rates of growth. Moreover, the firm maintains 16% worldwide orthopaedic market share; Stryker retains more of the orthopaedic market than any other of the nation’s foremost producers in the segment: DePuy Orthopaedics, Zimmer Holdings, Medtronic, Synthes, Smith & Nephew, and Biomet, among others. 3 Analysts remain speculative whether similar figures can be achieved for the current fiscal year citing regulatory issues and the costly mitigation so associated. 4

Corporate governance

As of 2008, members of the board of directors of Stryker Corporation are:5

  • John W. Brown, Chairman
  • Stephen P. MacMillan
  • Howard E. Cox, Jr.
  • Donald M. Engelman, Ph.D.
  • Louise L. Francesconi
  • William U. Parfet
  • Ronda E. Stryker

Recent acquisitions

In March 2006 Stryker absorbed the Haifra, Israel based Sightline Technologies Ltd. into its operations. Siteline, a manufacturer of gastrointestinal endoscopy apparatuses, propelled Stryker into the flexible endoscopy market. In February of the same year, the firm acquired eTrauma.com Corp., a privately held entity involved in the development of software for "Picture archiving and communication system" (PACS); the company was incorporated into Stryker Endoscopy Business. December 2005, marked the company’s acquisition, by merger, of PlasmaSol Corp. for $17.5 million. PlasmaSol produces technologies allowing sterilization of various MedSurg equipments. In August 2004, Stryker acquired, for $120 million, SpineCore Inc., a company involved in the development of artificial spinal disks. About two years preceding this date, in June of 2002, the firm acquired the Spinal Implant Business of Surgical Dynamics Inc. for $135 million. Two years prior to this date, in August of 2000, Stryker acquired, with stock, Guided Technologies, Inc., a developer and manufacturer of optical localizers purposed for use in healthcare and industrial.6 In 1998, Stryker purchased Howmedica, the orthopaedic division of Pfizer, for $1.65 billion.

Sponsorships

Stryker maintains relationships with, but not limited to, the following professional and trade organizations:7

  • The Advanced Medical Technology Association (AdvaMed)
  • The Medical Devices Manufacturing Association (MDMA)
  • The Orthopedic Research and Education Foundation (OREF)
  • National Electrical Manufacturers Association (NEMA)
  • European Federation of National Associations of Orthopaedics and Traumatology (EFORT)
  • International Society of Orthopaedic Surgery and Traumatology (SICOT)
  • International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS)
  • Foundation for Orthopaedic Trauma; Speaking of Women’s Health
  • Arthritis Foundation and American Academy of Orthopaedic Surgeons (AAOS)
  • Association of Perioperative Registered Nurses (AORN)
  • American Orthopaedic Society for Sports Medicine (AOSSM)

Regulatory controversies

Since early 2007 the company has received three letters from the Federal Drug Administration citing issues in compliancy.8 The first of which, a seven-page correspondence, named various issues at an Ireland based manufacturing facility such as untimely fix of failures and procedural noncompliance in the testing of failed or otherwise problem-prone devices.9 The second of which, sent November 2007, cites issues at the firm’s Mahwah, N.J. facility including poor fixation of hip implant components, in some instances requiring mitigation by revision surgeries; exceeded microbial level violations in the cleaning and final packaging areas of the sterile implants; and failure to institute measures in prevention of recurrence of these and other problems. 10 The final warning letter, sent April 2008, cites issues at the firm’s Hopkinton, Mass. biotechnology facility. Again, issues relate to quality and noncompliance including falsification of documents relevant to the selling of products to hospitals which are to be sold under a limited, government mandated basis. Stryker maintains that employees involved in the falsification of documents have since been terminated. 11

In fall 2007, Stryker along with the related companies: Biomet, Zimmer Holdings, DePuy Orthopaedics and Smith & Nephew, were involved in civil ligation with the U.S. Department of Health and Human Services, Office of Inspector General. This litigation called for a net payout of $311 million as the governmental department maintains the aforementioned companies engaged in unlawful kickbacks to physicians who urged hospitals to purchase their respective products. Stryker, however, having cooperated early in the investigation, was not fined. 12

As of February 2008 a dispute exists between Stryker Corp. and the U.S. Department of Justice concerning a subpoena linking the company to aforementioned misconduct in sale of products. Since governmental filing of the injunction, Stryker notes that it has produced in excess of 300,000 pages of documentation in compliance with the mandate. U.S. Government counters, however, that the documentation was not proper in scope and format. Law officials expect the investigation to persist several months. 13

史赛克大中华区

  美国史赛克公司早在1986年及1988 年便通过代理公司分别进入台湾及中国大陆市场,并于1994年正式在香港成立办事处,于2000年在北京、上海、广州及成都设立代表处。同时,分别在多个城市设立维修中心,确保能为顾客提供最及时可靠的服务。

  为表达对中国市场的重视,2005年10月美国史赛克公司在中国首都北京举行首次美国境外的董事局会议,表决将中国市场定为策略性高增长地区。2006年成立史赛克(北京)医疗器械有限公司,以更有效整合资源及发挥大中华各地区的优势。

  为了支持快速增长的业务,史赛克在大中华区会扩大售后维修服务范围并建立多个培训基地,以便为医护提供最佳的售前售后服务;同时,积极培养内部人才以提供最优秀的服务给我们的顾客。因为我们深信,医院能成功为患者提供医疗保健,才是我们的成功。

→如果您认为本词条还有待完善,请 编辑词条

词条内容仅供参考,如果您需要解决具体问题
(尤其在法律、医学等领域),建议您咨询相关领域专业人士。
0

标签: 史赛克公司

收藏到: Favorites  

同义词: 暂无同义词

关于本词条的评论 (共0条)发表评论>>

对词条发表评论

评论长度最大为200个字符。